Showing 8081-8090 of 8647 results for "".
- Teprotumumab Improves Bulging, QOL in Thyroid Eye Diseasehttps://modernod.com/news/teprotumumab-improves-bulging-qol-in-thyroid-eye-disease/2477078/Teprotumumab, a monoclonal antibody inhibitor of the IGF1 receptor, shows efficacy, including improvements in quality of life, in the treatment of moderate to severe thyroid eye disease, according to a report in Medscape. “In
- Intravitreous Ranibizumab Cost-Effective for Some With Proliferative Diabetic Retinopathyhttps://modernod.com/news/intravitreous-ranibizumab-cost-effective-for-some-with-proliferative-diabetic-retinopathy/2477079/At 5 years, intravitreous ranibizumab therapy for proliferative diabetic retinopathy (DR) appears to be cost-effective relative to panretinal photocoagulation (PRP), but only in eyes with vision-impairing center-involved diabetic macular edema (CI-DME), according to new findings
- Vision Plan Customer Satisfaction Increases, J.D. Power Findshttps://modernod.com/news/vision-plan-customer-satisfaction-increases-j-d-power-finds/2477073/Overall customer satisfaction among vision plan members has increased in 2019, driven by improved perceptions of value and coverage. According to the J.D. Power 2019 Vision Plan Satisfaction Report, overall satisfaction increased by 17 points (on a 1,000-point scale) to 770 this year from 753 in
- New ECP and Parent Survey Shows the Significant Need for Myopia Educationhttps://modernod.com/news/new-ecp-and-parent-survey-shows-the-significant-need-for-myopia-education/2477070/One in four children in the United States is myopic, but according to The Harris Poll survey results released by CooperVision, only 33% of parents know what that term means,2 or how it can affect their children’s future eyesight. This corroborates the finding that 97% of ECPs agree par
- Trump to Nominate Stephen Hahn, Cancer Researcher, to Head FDAhttps://modernod.com/news/trump-to-nominate-stephen-hahn-cancer-researcher-to-head-fda/2477068/President Trump said Friday that he intended to nominate Stephen M. Hahn, MD, a top executive at The University of Texas M.D. Anderson Cancer Center, to be the next commissioner of the Food and Drug Administration, according to a
- EyePrint Prosthetics Releases New Scleral Lens Technology: ScanFitPROhttps://modernod.com/news/eyeprint-prosthetics-releases-new-scleral-lens-technology-scanfitpro/2477058/EyePrint Prosthetics has announced the development of its new scleral lens fitting software, ScanFitPRO. This new technology simplifies every-day contact lens fitting by employing EyePrint Prosthetic’s scleral lens designer algorithm to automatically design a lens in 3-dimensional space, accordin
- Manufacturers, Providers Increasingly Rely on Premium Cataract Surgery Revenuehttps://modernod.com/news/manufacturers-providers-increasingly-rely-on-premium-cataract-surgery-revenue/2477057/The importance of premium cataract surgery to manufacturers, surgeons, and surgery centers alike grows, as reimbursements for cataract surgery under nationalized health care systems worldwide continue to decline, according to a Market Scope report. The reduction in cataract surgery reimbur
- NovaBay Pharmaceuticals to Distribute the NuLids System for the Treatment of Dry Eye in Certain U.S. Geographieshttps://modernod.com/news/novabay-pharmaceuticals-to-distribute-the-nulids-system-for-the-treatment-of-dry-eye-in-certain-u-s-geographies/2477048/NovaBay Pharmaceuticals announced an exclusive 90-day agreement with NuSight Medical to distribute the NuLids System for treatment of blepharitis and dry eye in six of NovaBay’s top-performing territories. The NuLids System is a hand-held, cordless device that safely and effectively removes accum
- More Evidence Links Common Bladder Drug to Retinal Damagehttps://modernod.com/news/more-evidence-links-common-bladder-drug-to-retinal-damage/2477044/Pentosan polysulfate sodium (PPS), used widely for interstitial cystitis, may lead to retinal damage, according to a new study that adds weight to this previously suggested link, as reported by Reuters. Interstitial cystitis causes
- Lineage Cell Therapeutics Presents Encouraging Data on Vision Restoration Programhttps://modernod.com/news/lineage-cell-therapeutics-presents-encouraging-data-on-vision-restoration-program/2477041/Lineage Cell Therapeutics announced today that Igor Nasonkin, PhD, Principal Investigator and Director of R&D, served as a co-Chair of the Neural Differentiation, Transplantation, and Regeneration Nanosymposium, in addition to presenting data on the company’s Vision Restoration Program at Neu